节点文献

TACE改善伴有肝外转移肝细胞癌患者预后

Transarterial chemoembolization improves the prognosis of patient with hepatocellular carcinoma accompanied by hepatic metastasis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 林峰郑双孟进施晓敏傅志仁

【Author】 LIN Feng1,ZHENG Shuang1,MENG Jin2,SHI Xiaomin2,FU Zhiren2(1.The First People’s Hospital of Taizhou,Zhejiang 318020,China;2.Shanghai Changzheng Hospital,Shanghai 200003,China)

【机构】 台州市第一人民医院上海长征医院

【摘要】 目的:探讨肝动脉化疗栓塞(TACE)对伴有肝外转移的肝细胞癌患者预后的影响。方法:回顾性分析本院2007年1月至2009年1月72例此类患者的临床资料,Kaplan-Meier法计算生存率,Log-rank检验和Cox回归模型分别进行预后单、多因素分析。结果:72例患者中Child A-B级63例,接受TACE或肝动脉灌注化疗(TACI),部分患者联合全身化疗(SC)或仅行保守治疗。最长随访时间35个月,死亡56例(88.9%)。患者1-,2年的总生存率分别为19.5%,7.4%。T1-2期(20例)行TACE/TACI+SC,TACE/TACI,SC和CM的患者中位生存时间分别为23,12,5,3个月,T3期(43例)患者对应数据为7,5,3,2个月。TACE/TACI单独使用或联合SC的治疗效果均显著优于CM(P<0.05)。Cox多因素分析发现高UICC/AJCC T分期,大血管侵犯,淋巴结或肺转移,未接受TACE/TACI治疗是影响患者预后的独立危险因素。结论:TACE/TACI能改善肝功能良好,伴肝外转移的HCC患者的预后,延长其生存时间。

【Abstract】 [Objective] To explore the influence of transarterial chemoembolization(TACE) in patients with extrahepatic metasitasis at initial diagnosis of hepatocellular carcinoma(HCC).[Method] Seventy two patients with extrahepatic metasitasis at initial diagnosis of HCC in our department from January 2007 and January 2009 were enrolled for this retrospective analysis.Patients were administrated TACE/TACI alone or plus systematic chemotherapy(SC) or only treated by conservative management(CM).SPSS13.0 software was used for statistical analysis.The Kaplan-Meier method was used to evaluate the survival rates.Log-rank test and Cox regression model were used to analysis the single and multi-factors for the prognosis.[Result]There were 63 patients with preserved liver function(Child A-B).The longest time of follow-up was 35 months,with a mortality of 88.9%.The 1-and 2-year overall survival rates were 19.5% and 7.4%,respectively.The median time of survival in patients(n=20) with T1-2 stage HCC was 23-,12-,5-and 3-month in TACE/TACI+SC,TACE/TACI,SC and CM group respectively,while the corresponding data for patients(n=43) with T3 stage HCC was 7-,5-,3-,2-month respectively.TACE/TACI alone or plus SC improved prognosis significantly than CM(P<0.05).Multivariate Cox regression analysis showed that the high UICC/AJCC T stage,macro-vascular invasive,lymph node and lung metastasis and untreated by TACE/TACI were independent prognostic factors.[Conclusion]TACE/TACI can significantly improve the prognosis of metastatic HCC patients with conserved liver function.

  • 【文献出处】 浙江医学教育 ,Zhejiang Medical Education , 编辑部邮箱 ,2013年01期
  • 【分类号】R735.7
  • 【被引频次】2
  • 【下载频次】27
节点文献中: 

本文链接的文献网络图示:

本文的引文网络